Losartan (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Losartan" in English language version.

Global rank English rank

31web.archive.org

1^st place

20fda.gov

447^th place

338^th place

12nih.gov

4^th place

7doi.org

2^nd place

3clincalc.com

3,912^th place

2,496^th place

2drugs.com

399^th place

333^rd place

2rxlist.com

7,927^th place

6,815^th place

2semanticscholar.org

11^th place

8^th place

1books.google.com

3^rd place

1handle.net

102^nd place

76^th place

1patents.google.com

1,182^nd place

725^th place

1nice.org.uk

3,258^th place

2,666^th place

1archive.org

6^th place

1archive-it.org

910^th place

593^rd place

1worldcat.org

5^th place

1jbc.org

4,455^th place

5,199^th place

archive-it.org

archive.org

books.google.com

Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 470. ISBN 9783527607495. Archived from the original on 28 August 2021. Retrieved 26 August 2020.

clincalc.com

doi.org

Boersma C, Atthobari J, Gansevoort RT, de Jong-Van den Berg LT, de Jong PE, de Zeeuw D, et al. (2006). "Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision making". PharmacoEconomics. 24 (6): 523–35. doi:10.2165/00019053-200624060-00001. PMID 16761901. S2CID 22960961.
Cheungpasitporn W, Thongprayoon C, Chiasakul T, Korpaisarn S, Erickson SB (November 2015). "Renin-angiotensin system inhibitors linked to anemia: a systematic review and meta-analysis". QJM. 108 (11): 879–884. doi:10.1093/qjmed/hcv049. PMID 25697787.
Patti R, Sinha A, Sharma S, Yoon TS, Kupfer Y (May 2019). "Losartan-induced Severe Hepatic Injury: A Case Report and Literature Review". Cureus. 11 (5): e4769. doi:10.7759/cureus.4769. PMC 6663042. PMID 31363450.
Graudal NA, Hubeck-Graudal T, Jürgens G (January 2012). "Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review)". American Journal of Hypertension. 25 (1): 1–15. doi:10.1038/ajh.2011.210. PMID 22068710.
Hamada T, Ichida K, Hosoyamada M, Mizuta E, Yanagihara K, et al. (1 October 2008). "Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients". American Journal of Hypertension. 21 (10): 1157–1162. doi:10.1038/ajh.2008.245. PMID 18670416.
Noda K, Saad Y, Kinoshita A, Boyle TP, Graham RM, Husain A, et al. (February 1995). "Tetrazole and carboxylate groups of angiotensin receptor antagonists bind to the same subsite by different mechanisms". The Journal of Biological Chemistry. 270 (5): 2284–2289. doi:10.1074/jbc.270.5.2284. PMID 7530721. Archived from the original on 19 September 2022. Retrieved 21 October 2017.
Sica DA, Gehr TW, Ghosh S (2005). "Clinical pharmacokinetics of losartan". Clin Pharmacokinet. 44 (8): 797–814. doi:10.2165/00003088-200544080-00003. PMID 16029066. S2CID 41326620.

drugs.com

"Losartan (Cozaar) Use During Pregnancy". Drugs.com. Archived from the original on 10 December 2017. Retrieved 10 December 2017.
"Losartan Potassium". The American Society of Health-System Pharmacists. Archived from the original on 10 December 2017. Retrieved 8 December 2017.

fda.gov

handle.net

World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.

jbc.org

Noda K, Saad Y, Kinoshita A, Boyle TP, Graham RM, Husain A, et al. (February 1995). "Tetrazole and carboxylate groups of angiotensin receptor antagonists bind to the same subsite by different mechanisms". The Journal of Biological Chemistry. 270 (5): 2284–2289. doi:10.1074/jbc.270.5.2284. PMID 7530721. Archived from the original on 19 September 2022. Retrieved 21 October 2017.

nice.org.uk

nih.gov

Boersma C, Atthobari J, Gansevoort RT, de Jong-Van den Berg LT, de Jong PE, de Zeeuw D, et al. (2006). "Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision making". PharmacoEconomics. 24 (6): 523–35. doi:10.2165/00019053-200624060-00001. PMID 16761901. S2CID 22960961.
Cheungpasitporn W, Thongprayoon C, Chiasakul T, Korpaisarn S, Erickson SB (November 2015). "Renin-angiotensin system inhibitors linked to anemia: a systematic review and meta-analysis". QJM. 108 (11): 879–884. doi:10.1093/qjmed/hcv049. PMID 25697787.
Patti R, Sinha A, Sharma S, Yoon TS, Kupfer Y (May 2019). "Losartan-induced Severe Hepatic Injury: A Case Report and Literature Review". Cureus. 11 (5): e4769. doi:10.7759/cureus.4769. PMC 6663042. PMID 31363450.
Graudal NA, Hubeck-Graudal T, Jürgens G (January 2012). "Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review)". American Journal of Hypertension. 25 (1): 1–15. doi:10.1038/ajh.2011.210. PMID 22068710.
Hamada T, Ichida K, Hosoyamada M, Mizuta E, Yanagihara K, et al. (1 October 2008). "Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients". American Journal of Hypertension. 21 (10): 1157–1162. doi:10.1038/ajh.2008.245. PMID 18670416.
Noda K, Saad Y, Kinoshita A, Boyle TP, Graham RM, Husain A, et al. (February 1995). "Tetrazole and carboxylate groups of angiotensin receptor antagonists bind to the same subsite by different mechanisms". The Journal of Biological Chemistry. 270 (5): 2284–2289. doi:10.1074/jbc.270.5.2284. PMID 7530721. Archived from the original on 19 September 2022. Retrieved 21 October 2017.
Sica DA, Gehr TW, Ghosh S (2005). "Clinical pharmacokinetics of losartan". Clin Pharmacokinet. 44 (8): 797–814. doi:10.2165/00003088-200544080-00003. PMID 16029066. S2CID 41326620.

patents.google.com

"Pharmaceutical formulation of losartan". Archived from the original on 5 January 2022. Retrieved 5 January 2022.

rxlist.com

"See negatively charged tetrazole structure". Archived from the original on 22 January 2021. Retrieved 21 October 2017.
RxList. The Internet Drug Index. Clinical pharmacology of Cozaar Archived 6 January 2014 at the Wayback Machine. Retrieved 6 January 2014.

semanticscholar.org

Boersma C, Atthobari J, Gansevoort RT, de Jong-Van den Berg LT, de Jong PE, de Zeeuw D, et al. (2006). "Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision making". PharmacoEconomics. 24 (6): 523–35. doi:10.2165/00019053-200624060-00001. PMID 16761901. S2CID 22960961.
Sica DA, Gehr TW, Ghosh S (2005). "Clinical pharmacokinetics of losartan". Clin Pharmacokinet. 44 (8): 797–814. doi:10.2165/00003088-200544080-00003. PMID 16029066. S2CID 41326620.

web.archive.org

worldcat.org

Katzung, Bertram G., ed. (30 November 2017). Basic & clinical pharmacology. McGraw-Hill Education. ISBN 9781259641152. OCLC 1048625746.

Losartan (English Wikipedia)

archive-it.org

wayback.archive-it.org

archive.org

books.google.com

clincalc.com

doi.org

drugs.com

fda.gov

fda.gov

nctr-crs.fda.gov

handle.net

hdl.handle.net

jbc.org

nice.org.uk

nih.gov

pubmed.ncbi.nlm.nih.gov

dailymed.nlm.nih.gov

ncbi.nlm.nih.gov

patents.google.com

rxlist.com

semanticscholar.org

api.semanticscholar.org

web.archive.org

worldcat.org

search.worldcat.org